|
Mankind Pharma Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
85999.68 Cr.
|
P/BV
|
5.63
|
Book Value (Rs.)
|
370.30
|
|
52 Week High/Low (Rs.)
|
2717/2033
|
FV/ML
|
1/1
|
P/E(X)
|
43.20
|
|
Bookclosure
|
08/08/2025
|
EPS (Rs.)
|
48.23
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 3567.20 | 3697.16 | 3570.35 | 3079.37 | 3230.00 |
| Total Income From Operations | 3567.20 | 3697.16 | 3570.35 | 3079.37 | 3230.00 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 553.04 | 594.36 | 585.68 | 554.25 | 536.11 |
| Purchase of Traded Goods | 411.67 | 412.97 | 404.97 | 411.12 | 387.30 |
| Increase/Decrease in Stocks | 13.28 | 54.84 | 62.94 | -89.99 | 11.81 |
| Employees Cost | 823.71 | 825.18 | 783.41 | 715.80 | 709.71 |
| Depreciation | 222.60 | 221.82 | 218.68 | 230.87 | 192.30 |
| Other Expenses | 846.07 | 888.48 | 886.58 | 805.00 | 755.27 |
| Total Expenses | 2870.37 | 2997.65 | 2942.26 | 2627.05 | 2592.50 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 696.83 | 699.51 | 628.09 | 452.32 | 637.50 |
| Other Income | 72.75 | 91.87 | 79.88 | 251.33 | 77.32 |
| P/L Before Interest, Excpt. Items & Tax | 769.58 | 791.38 | 707.97 | 703.65 | 714.82 |
| Interest | 157.20 | 169.68 | 170.65 | 190.54 | 220.93 |
| P/L Before Exceptional Items & Tax | 612.38 | 621.70 | 537.32 | 513.11 | 493.89 |
| Exceptional Items | -106.59 | 0.00 | 0.00 | 0.00 | 0.00 |
| P/L Before Tax | 505.79 | 621.70 | 537.32 | 513.11 | 493.89 |
| Tax | 95.12 | 103.84 | 95.87 | 86.44 | 112.81 |
| P/L After Tax from Ordinary Activities | 410.67 | 517.86 | 441.45 | 426.67 | 381.08 |
| Extra Ordinary Item | 0.00 | 0.00 | 0.00 | -4.34 | 0.00 |
| Net Profit/Loss For the Period | 410.67 | 517.86 | 441.45 | 422.33 | 381.08 |
| Minority Interest | -5.13 | -8.67 | -6.30 | -3.88 | -4.29 |
| Share Of P/L Of Associates | 3.21 | 2.32 | 3.17 | 2.32 | 3.44 |
| Net P/L After Minority Interest & Share Of Associates | 408.75 | 511.51 | 438.32 | 420.77 | 380.23 |
| | | | | | |
| Equity Share Capital | 41.28 | 41.28 | 41.26 | 41.26 | 40.06 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 9.90 | 12.39 | 10.62 | 10.20 | 9.45 |
| Diluted EPS (Rs.) | 9.89 | 12.38 | 10.60 | 10.18 | 9.44 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 9.90 | 12.39 | 10.62 | 10.20 | 9.45 |
| Diluted EPS (Rs.) | 9.89 | 12.38 | 10.60 | 10.18 | 9.44 |
| | | | | | |
| PBITOE Margin (%) | 19.53 | 18.92 | 17.59 | 14.68 | 19.73 |
| PBTE Margin (%) | 17.16 | 16.81 | 15.04 | 16.66 | 15.29 |
| PBT Margin (%) | 14.17 | 16.81 | 15.04 | 16.66 | 15.29 |
| PAT Margin (%) | 11.51 | 14.00 | 12.36 | 13.71 | 11.79 |
| PAT After MI And SOA Margin (%) | 11.45 | 13.83 | 12.27 | 13.66 | 11.77 |
